Drug Discovery Market Research Reports & Industry Analysis
Drug discovery is the systematic process of identifying, designing, and developing new pharmaceutical compounds or therapies to treat specific diseases or medical conditions. This is a high-cost, risky business because only a fraction of the therapeutic targets selected for study will yield products that achieve regulatory approval by the Food & Drug Administration (FDA). To help stakeholders navigate this complex market, MarketResearch.com offers a suite of comprehensive drug discovery reports on industries big and small.
Understanding the Drug Discovery Market
- Our compilation of reports features thousands of reports from leading research firms, allowing you to access highly targeted information.
- We provide a rich repository of data, including analysis of drug discovery market trends, forecasts, growth opportunities, and strategies.
- We also provide expert commentary on disruptive technologies and the use of artificial intelligence, machine learning, and blockchain in drug discovery.
Informed Insights: Your Path to Success
Whether you're an industry professional, a consultant, or an executive, our research collection provides credible data to help you make informed decisions that catalyze growth. For decades, we have served top pharmaceutical companies, investment banks, and consulting firms as a trusted research partner. Uncover new opportunities and stay ahead of the curve with MarketResearch.com's drug discovery industry reports.
Drug Discovery Industry Research & Market Reports
-
Chronic lymphocytic leukemia- Pipeline Insight, 2024
... profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered ... Read More
-
Chronic Myeloid Leukemia - Pipeline Insight, 2024
... drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography ... Read More
-
Retinitis Pigmentosa (RP) - Competitive Landscape
... in the 16 countries covered in GlobalData’s epidemiology forecast for RP. The treatment guidelines for RP have been well established globally. Roche’s Luxturna (voretigene neparvovec) dominate the RP market. Majority of RP pipeline assets are ... Read More
-
Precision medicine Market Assessment, By Use [Diagnostics, Therapeutics], By Application [Central Nervous System, Respiratory, Immunology, Oncology, Others], By Technology [Point-of-care Testing, Stem Cell Therapy, Pharmacogenomics, Pharmacoproteomics, Others], By End-user [Pharmaceutical Companies, Diagnostic Companies, Healthcare IT Companies, Others], By Region, Opportunities and Forecast, 2017-2031F
... Companies, Others], By Region, Opportunities and Forecast, 2017-2031F The global precision medicine market is projected to witness a CAGR of 9.73% during the forecast period 2024-2031, growing from USD 51.69 billion in 2023 to USD ... Read More
-
Peripheral Artery Disease (PAD): Competitive Landscape
... in the 16 countries covered in GlobalData’s epidemiology forecast for PAD. The innovator marketed drugs space for PAD includes coagulation factor X inhibitors, fibrinogen activators, hepatocyte growth factor activators, and vascular endothelial growth factor activators, ... Read More
-
Fuchs Endothelial Corneal Dystrophy (FECD): Competitive Landscape
... 2024 in the 16 countries covered in GlobalData’s epidemiology forecast for FECD. Currently there are no FDA approved therapies for FECD. The most recent guideline for FECD was developed by the American Academy of Ophthalmology. ... Read More
-
Scaffold Technology Market, By Material Type (Natural, Synthetic, Bio-ceramics, Biodegradable Metals, Carbon-based Nanomaterials), By Printing Technology (Bioprinting, 3D Printing, Selective Laser Sintering, Stereolithography, Thermal-Induced Phase Separation Method, Others), By Application (Tissue Engineering, Stem Cell Research, Drug Development & Discovery, Others), By End User (Biopharmaceutical Companies, Academic & Research Institutes, Hospitals & Clinics, Others), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East and Africa)
... Drug Development & Discovery, Others), By End User (Biopharmaceutical Companies, Academic & Research Institutes, Hospitals & Clinics, Others), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East and Africa) Scaffold technology is a ... Read More
-
Gastrointestinal Therapeutics and Diagnostics: Technologies and Global Markets
... participants. The scope of the study is global. This report estimates market data for 2022 (the base year) and forecasts for 2023 through 2028. Figures for 2023 are estimated, except where actual results have been ... Read More
-
Global Postmenopausal Vaginal Atrophy Drugs Market Growth 2024-2030
... downstream market, the Postmenopausal Vaginal Atrophy Drugs is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the ... Read More
-
Meningococcal Vaccines Market Report 2024-2034
... dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region. Difficulties in R&D Introduction of vaccine requires immense amount of ... Read More
-
Eosinophilic Esophagitis Market, by Drug Class (Corticosteroids: Budesonide {Jorveza and Off-label budesonide} and Fluticasone; Proton Pump Inhibitor (PPI): Omeprazole, Esomeprazole, and Others; and Late Stage Pipeline Drugs: Dupixent, APT-1011, Lirentelimab (AK002), Cendakimab, Etrasimod, TAK-721, and Omilancor (BT-11)), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2024 - 2031
... Omilancor (BT-11)), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2024 - ... Read More
-
Klebsiella Pneumoniae Infections - Epidemiology Forecast - 2034
... i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan. Geographies Covered The United States EU5 (Germany, France, Italy, Spain, and the United Kingdom) Japan Study Period: 2020-2034 Klebsiella Pneumoniae ... Read More
-
Global Drug Discovery Outsourcing Market 2024-2028
... drug discovery outsourcing market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current ... Read More
-
Global Antipsychotic Drugs Market Size Study & Forecast, by Disease (Schizophrenia, Bipolar Disorder, Unipolar Depression, Dementia, and Others), By Drug (Risperidone, Quetiapine, Olanzapine, Aripiprazole, Brexpiprazole, Paliperidone Palmitate, and Others), By Therapeutic Class (First Generation, Second Generation, and Third Generation), By Distribution Channel (Hospital Pharmacies, Drug Stores & Retail Pharmacies, and Online Pharmacies), and Regional Analysis, 2023-2030
... Generation, and Third Generation), By Distribution Channel (Hospital Pharmacies, Drug Stores & Retail Pharmacies, and Online Pharmacies), and Regional Analysis, 2023-2030 Global Antipsychotic Drugs Market is valued approximately at USD 15.47 billion in 2022 and ... Read More
-
Augmented Reality in Healthcare - Thematic Research
... be worth $100 billion by 2030, up from $22 billion in 2022. Rather than enable entirely new processes, healthcare companies should use AR to improve existing processes. AR has uses in healthcare professional training, R&D, ... Read More
-
Weight Loss Drugs Global Market Report 2024
... Merck & Co.; AbbVie Inc.; Novartis AG Weight Loss Drugs Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market. ... Read More
-
Global Prader-Willi Syndrome (PWS) Therapeutics Market Professional Survey by Types, Applications, and Players, with Regional Growth Rate Analysis and Development Situation, from 2023 to 2028
... market growth of the Prader-Willi Syndrome (PWS) Therapeutics industry between the year 2018 to 2028, and breaks down according to the product type, downstream application, and consumption area of Prader-Willi Syndrome (PWS) Therapeutics. The report ... Read More
-
Gastrointestinal Therapeutics Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)
... billion by 2029, growing at a CAGR of 3.80% during the forecast period (2024-2029). Factors such as the increasing prevalence of gastrointestinal diseases and the rising investments in research and development by pharmaceutical companies are ... Read More
-
Global Chronic Lymphocytic Leukemia Therapeutics Market 2024-2028
... the chronic lymphocytic leukemia therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding ... Read More
-
Drug Discovery Informatics Market Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Workflow (Discovery Informatics and Drug Development), Service (Sequence Analysis Platform, Molecular Modeling, Clinical Trial Data Management, Docking, and Others), Solution (Software and Services), End User (Pharmaceutical and Biotechnology Companies, Contract Research Organizations, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
... Trial Data Management, Docking, and Others), Solution (Software and Services), End User (Pharmaceutical and Biotechnology Companies, Contract Research Organizations, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & ... Read More
-
Women's Health Market Report 2024-2034
... dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region. Growing awareness about women's health issues The women's health market ... Read More
-
2024 Global Forecast for Narcolepsy Drug Market (2025-2030 Outlook)-High Tech & Emerging Markets Report
... or service category is within the NAICS Medical Laboratories industry. The product or service category is within the NAICS Medical Laboratories industry. The global market is expected to increase from USD xx billion in 2025 ... Read More
-
2024 Global: Breast Cancer Therapeutics - Innovative Markets Forecast (2030) report
... 2019 through 2030. Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2019 to 2030 using regression ... Read More
-
2024 Global Forecast for Alzheimer'S Disease Drug Market (2025-2030 Outlook)-High Tech & Emerging Markets Report
... product or service category is within the NAICS Medical Laboratories industry. The product or service category is within the NAICS Medical Laboratories industry. The global market is expected to increase from USD xx billion in ... Read More
-
Monoclonal Antibody (mABs) Therapeutics Market by Production Method (In-Vitro, In-Vivo), Sources (Human, Chimeric), Route of Administration (Intravenous, Subcutaneous), Therapy (Inflammatory & Autoimmune, Oncology, Hematology) - Global Forecast to 2029
... projected to reach USD 497.5 billion by 2029 from an estimated USD 252.6 billion in 2024, at a CAGR of 14.5% during the forecast period. The driving factors of the monoclonal antibody therapeutics market include ... Read More